Susan Katherine Logan

Title: Susan Katherine Logan: Innovator in Pharmaceutical Compounds

Introduction

Susan Katherine Logan is a prominent inventor based in New York, NY (US). She has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target critical biological pathways. With a total of 2 patents, her work has the potential to impact various medical conditions.

Latest Patents

Logan's latest patents include innovative compounds that serve as beta-catenin modulators. The first patent details a series of oxazole and thiazole compounds that act as small molecule inhibitors of the Wnt pathway, specifically targeting the activity of the stabilized pool of β-catenin. These compounds may be formulated as pharmaceutical compositions for the prevention and treatment of various conditions, including cancer. The second patent focuses on antibodies that recognize and bind to phosphorylated human androgen receptors. This phosphorylation site-specific antibody can be utilized to determine the presence of activated androgen receptors in human androgen-responsive tissues and for screening androgen inhibitors or agonists.

Career Highlights

Susan Katherine Logan is affiliated with New York University, where she continues her research and development efforts. Her work is characterized by a commitment to advancing medical science through innovative solutions.

Collaborations

Logan collaborates with notable colleagues, including Ramanuj Dasgupta and Eugine Lee, who contribute to her research endeavors.

Conclusion

Susan Katherine Logan is a trailblazer in the field of pharmaceutical innovations, with her patents paving the way for new treatments in medicine. Her contributions are invaluable to the scientific community and hold promise for future advancements.